HOME >> MEDICINE >> NEWS
Radiation, chemotherapy before surgery controls rectal cancer

For patients with rectal cancer, receiving radiation therapy and chemotherapy before surgery to shrink the tumor so it can be more easily removed helps keep the cancer from coming back, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.

Beginning in 1992, doctors in France enrolled 733 patients suffering from rectal cancer into the study. The patients were split into two groups the first received radiation alone for five weeks before undergoing surgery to remove the cancer. The second group received chemotherapy in addition to five weeks of radiation therapy prior to surgery.

"The standard treatment for rectal cancer has been radiation therapy alone before surgery, but this is the first randomized study to prove that adding chemotherapy to the treatment helps patients beat their cancer," said Pascale Romestaing, M.D., co-author of the study and a radiation oncologist at CHU Lyon Sud in Lyon, France.

The doctors discovered that while combining radiation therapy and chemotherapy does not significantly increase survival rates, it does improve local tumor control and helps to keep the cancer from returning. The last phase of the trial, from 1999 to 2003, showed that only eight percent of the patients saw their cancer return five years after receiving treatment.

"This treatment should be recommended as the standard for the majority of rectal cancer patients," said Jean-Pierre Gerard, M.D., lead author of the study and a radiation oncologist at the Centre Antoine-Lacassagne in Nice, France.


'"/>

Contact: Beth Bukata
bethb@astro.org
703-431-2332
American Society for Therapeutic Radiology and Oncology
17-Oct-2005


Page: 1

Related medicine news :

1. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
2. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
3. Brain-boosting pill alleviates post-chemotherapy fogginess
4. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
5. Most pediatric chemotherapy mistakes reach patients
6. Growth factors given with chemotherapy associated with increased risk of blood diseases
7. Clear guidelines on oral chemotherapy needed
8. Survey reveals need for standardized oral chemotherapy prescribing practices, safeguards
9. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
10. Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival
11. Order of chemotherapy, radiation has no effect on breast cancer survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally ... the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists ... be aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... NJ (PRWEB) , ... March 28, 2017 , ... ... Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was a busy ... their team of professional staff discussed strategies for preventing outbreaks among camp communities ...
(Date:3/28/2017)... ... 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader ... women’s hair loss. Although hair transplant procedures can be seen as more of a ... can be two reasons a woman may see her hair thinning. , “We are ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 ... Israel . This new business entity, Emosis Ltd, headquartered in ... research and development of novel assays complementing the mother company existing ... locally support commercialization and sales development of Emosis kits. ... This strategic move starts building ...
(Date:3/28/2017)...  CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical ... other unmet medical needs, announced today two poster ... annual meeting.  The first poster to be presented ... ENMD-2076 in Combination with Anti-PD1 in Syngeneic Cancer ... presented on April 4 is entitled " Kinase ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology:
Cached News: